Mitoxantrone Hydrochloride Liposome Combined With Rituximab and Lenalidomide (M+R2) in Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma

NCT05575973 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome
DRUG: Rituximab
DRUG: Lenalidomide

Sponsor

Jianfeng Zhou

Collaborators

[object Object]